Charles Schwab Investment Management Inc. Grows Stake in Astrana Health, Inc. $ASTH

Key Points

• Charles Schwab Investment Management Inc. increased its holdings in Astrana Health, Inc. by 6.0% in Q1, owning 499,529 shares worth $15.49 million at the end of the reporting period.
• Astrana Health reported a loss per share of $0.19 for the last quarter, missing analyst estimates, despite revenue growing 34.7% year-over-year to $654.81 million.
• Institutional investors hold 52.77% of Astrana Health's stock, with several firms like Quarry LP and US Bancorp DE significantly increasing their stakes recently.

Charles Schwab Investment Management Inc. grew its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 6.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 499,529 shares of the company's stock after buying an additional 28,200 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.89% of Astrana Health worth $15,490,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP raised its holdings in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares during the period. US Bancorp DE raised its holdings in Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares during the period. PharVision Advisers LLC bought a new position in Astrana Health in the 4th quarter worth $211,000. Envestnet Asset Management Inc. raised its holdings in Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock worth $225,000 after purchasing an additional 1,184 shares during the period. Finally, City Center Advisors LLC bought a new position in Astrana Health in the 1st quarter worth $276,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Stock Performance

Astrana Health stock traded up $0.12 during trading on Thursday, reaching $31.33. The company had a trading volume of 394,923 shares, compared to its average volume of 498,994. Astrana Health, Inc. has a 52 week low of $21.20 and a 52 week high of $63.20. The firm's 50-day simple moving average is $25.75 and its 200 day simple moving average is $28.52. The firm has a market capitalization of $1.76 billion, a price-to-earnings ratio of 61.43, a price-to-earnings-growth ratio of 0.78 and a beta of 0.85. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The company had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. During the same period in the prior year, the business posted $0.40 earnings per share. Astrana Health's revenue for the quarter was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. Sell-side analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.